ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000

NCI Director Harold Varmus Plans New Center For Cancer Genomics To Lead The Cancer Genome Atlas Program.

September 10, 2010

CTEP Starts New Effort to Bring Minorities Into Clinical Trials

March 2, 1990

St. Jude Begins $100 Million Expansion Program

December 4, 1987